BCRXBIOCRYST PHARMACEUTICALS INC
CUSIP 09058V103 · common stock
4 tracked investors held BIOCRYST PHARMACEUTICALS INC (BCRX) at the end of Q3 2026, worth $113.9M in total. The largest holder was Perceptive Advisors, with 1.5% of its portfolio. RA Capital Management sold out of its position this quarter.
Holders · Q3 2026
4
New holders
0
Value held
$113.9M
Quarter-end price (est.)
$8.33
Investors holding BCRX · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Perceptive Advisors Perceptive Advisors LLC | 1.49% | 10,301,888 | $85.8M | REDUCE-0.1% |
| Ken Fisher Fisher Asset Management, LLC | 0.01% | 2,448,598 | $20.4M | REDUCE-6.0% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.01% | 471,090 | $3.9M | ADD+201.2% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.16% | 447,105 | $3.7M | ADD+236.2% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| RA Capital Management | 1.38% | 15,827,186 | $158.3M | EXIT |